Related Experiment Video
Updated: Feb 2, 2026

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
1Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama; kuboyama@inm.u-toyama.ac.jp.
Abstract:
Amyloid-β (Aβ) causes memory impairments in Alzheimer's disease (AD). Although therapeutics have been shown to reduce Aβ levels in the brains of AD patients, these do not improve memory functions. Since Aβ aggregates in the brain before the appearance of memory impairments, targeting Aβ may be inefficient for treating AD patients who already exhibit memory deficits. Therefore, downstream signaling due to Aβ deposition should be blocked before AD development. Aβ induces axonal degeneration, leading to the disruption of neuronal networks and memory impairments. Although there are many studies on the mechanisms of Aβ toxicity, the source of Aβ toxicity remains unknown. To help identify the source, we propose a novel protocol that uses microscopy, gene transfection, and live cell imaging to investigate early changes caused by Aβ in axonal growth cones of cultured neurons. This protocol revealed that Aβ induced clathrin-mediated endocytosis in axonal growth cones followed by growth cone collapse, demonstrating that inhibition of endocytosis prevents Aβ toxicity. This protocol will be useful in studying the early effects of Aβ and may lead to more efficient and preventative AD treatment.
Insights
Amyloid-beta (Aβ) triggers memory loss in Alzheimer's disease by damaging neurons. Blocking Aβ-induced endocytosis in growth cones prevents this toxicity, offering a new therapeutic target for early Alzheimer's treatment.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Alzheimer's disease (AD) is characterized by memory impairments linked to Amyloid-beta (Aβ) plaques.
- Current Aβ-targeting therapies often fail to restore memory in patients with existing deficits.
- The precise source of Aβ toxicity, particularly its early cellular mechanisms, remains unclear.
Purpose of the Study:
- To investigate the early molecular mechanisms of Aβ toxicity in neuronal growth cones.
- To identify the cellular source of Aβ-induced axonal degeneration and memory deficits.
- To develop a novel protocol for studying early Aβ effects in cultured neurons.
Main Methods:
- Utilized a novel protocol combining microscopy, gene transfection, and live cell imaging.
- Examined early changes in axonal growth cones of cultured neurons exposed to Aβ.
- Investigated the role of endocytosis in Aβ-induced neurotoxicity.
Main Results:
- Amyloid-beta (Aβ) was found to induce clathrin-mediated endocytosis in axonal growth cones.
- This Aβ-induced endocytosis led to subsequent growth cone collapse.
- Inhibition of endocytosis effectively prevented Aβ-induced toxicity in neurons.
Conclusions:
- Aβ toxicity in Alzheimer's disease originates from its induction of endocytosis in axonal growth cones.
- Blocking this early endocytic pathway presents a promising strategy for preventative or early-stage AD treatment.
- The developed protocol offers a valuable tool for studying early Aβ pathogenesis and evaluating novel therapeutic interventions.
Related Concept Videos
Neurons: The Axon
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment....
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Population Growth
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Meristems and Plant Growth

